K. Mross
- Oncology top 0.5%
- Cancer Treatment and Pharmacology 61
- Colorectal Cancer Treatments and Studies 20
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 12
- Cancer Research top 5%
- Pharmacology top 1%
-
- Lung Cancer Treatments and Mutations 12
-
- Chemotherapy-induced cardiotoxicity and mitigation 21
-
- Angiogenesis and VEGF in Cancer 15
-
- Multiple Myeloma Research and Treatments 11
-
- Microtubule and mitosis dynamics 9
- Co-authors
- Clemens UngerAlex SparreboomStephan MielkeAnnette FrostSimone SteinbildMichael MedingerJoachim DrevsDirk Behringer
- Cited by
- OncologyHepatologyCancer Research
- Journals
- Journal of Clinical Oncology (23 papers)European Journal of Cancer (8 papers)Annals of Oncology (8 papers)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
K. Mross
145 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 123
- Oncology 3.1k
- Hepatology 395
- Cancer Research 606
- Pharmacology 326
- Pulmonary and Respiratory Medicine 1.0k
Countries citing papers authored by K. Mross
This map shows the geographic impact of K. Mross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Mross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Mross more than expected).
Fields of papers citing papers by K. Mross
This network shows the impact of papers produced by K. Mross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Mross. The network helps show where K. Mross may publish in the future.
Co-authorship network
The 25 scholars most cited alongside K. Mross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 41 | |
| 2 | 2012 | 262 | |
| 3 | 2011 | 79 | |
| 4 | 2009 | 1 | |
| 5 | 2006 | 13 | |
| 6 | 2003 | 69 | |
| 7 | 2003 | 31 | |
| 8 | 2000 | 49 | |
| 9 | 1998 | 15 | |
| 10 | 1996 | 14 | |
| 11 | 1995 | 1 | |
| 12 | 1994 | 2 | |
| 13 | 1993 | 3 | |
| 14 | 1993 | 1 | |
| 15 | 1992 | 11 | |
| 16 | 1992 | 5 | |
| 17 | Phase I/II study of intravesical epirubicin in patients with carcinoma in situ of the bladder. | 1990 | 5 |
| 18 | 1990 | 9 | |
| 19 | 1988 | 11 | |
| 20 | 1988 | 156 |
About K. Mross
K. Mross is a scholar working on Oncology, Hepatology and Hematology, having authored 148 papers that have together received 5.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (61 papers), Chemotherapy-induced cardiotoxicity and mitigation (21 papers), Colorectal Cancer Treatments and Studies (20 papers), Angiogenesis and VEGF in Cancer (15 papers), Lung Cancer Treatments and Mutations (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Multiple Myeloma Research and Treatments (11 papers) and Microtubule and mitosis dynamics (9 papers). The work is most often cited by research in Oncology (3.1k citations), Hepatology (395 citations) and Cancer Research (606 citations). K. Mross has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Clemens Unger, Alex Sparreboom, Stephan Mielke, Annette Frost, Simone Steinbild, Michael Medinger, Joachim Drevs, Dirk Behringer, M. E. Scheulen and Martin Büchert. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Cancer Chemotherapy and Pharmacology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.